Literature DB >> 32319022

The immunopathobiology of T cells in stress condition: a review.

Mostafa Khedri1,2, Azam Samei1, Mahdi Fasihi-Ramandi3, Ramezan Ali Taheri4.   

Abstract

Several factors impact the immune responses such as the chemical nature of antigens, the physiologic and metabolic condition of the responsive cells, the site of antigen recognition, and neuroendocrine and pharmacological received agents. Incompatibility of host immune responses to the entrapped antigens leads to an immune pathological manner instead of an immune protection which results in the disharmony of the immune effective factors. Besides the fact that stress is one of the most common effective factors in human life, it also contributed to the protection, suppression, and pathology of the immune system. In this review article, the direct and indirect effects of the stress on the function of T cells and the contributed mechanism of action will be discussed.

Entities:  

Keywords:  CNS; Pathology; Stress; T cell

Mesh:

Year:  2020        PMID: 32319022      PMCID: PMC7479667          DOI: 10.1007/s12192-020-01105-0

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  51 in total

1.  Protective autoimmunity is a physiological response to CNS trauma.

Authors:  E Yoles; E Hauben; O Palgi; E Agranov; A Gothilf; A Cohen; V Kuchroo; I R Cohen; H Weiner; M Schwartz
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  A mechanism converting psychosocial stress into mononuclear cell activation.

Authors:  Angelika Bierhaus; Jutta Wolf; Martin Andrassy; Nicolas Rohleder; Per M Humpert; Dimitri Petrov; Roman Ferstl; Maximilian von Eynatten; Thoralf Wendt; Gottfried Rudofsky; Martina Joswig; Michael Morcos; Markus Schwaninger; Bruce McEwen; Clemens Kirschbaum; Peter P Nawroth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

Review 3.  The role of inflammation in depression: from evolutionary imperative to modern treatment target.

Authors:  Andrew H Miller; Charles L Raison
Journal:  Nat Rev Immunol       Date:  2016-01       Impact factor: 53.106

4.  Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets.

Authors:  Ryan D Michalek; Valerie A Gerriets; Sarah R Jacobs; Andrew N Macintyre; Nancie J MacIver; Emily F Mason; Sarah A Sullivan; Amanda G Nichols; Jeffrey C Rathmell
Journal:  J Immunol       Date:  2011-02-11       Impact factor: 5.422

5.  MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4.

Authors:  James T Walsh; Sven Hendrix; Francesco Boato; Igor Smirnov; Jingjing Zheng; John R Lukens; Sachin Gadani; Daniel Hechler; Greta Gölz; Karen Rosenberger; Thomas Kammertöns; Johannes Vogt; Christina Vogelaar; Volker Siffrin; Ali Radjavi; Anthony Fernandez-Castaneda; Alban Gaultier; Ralf Gold; Thirumala-Devi Kanneganti; Robert Nitsch; Frauke Zipp; Jonathan Kipnis
Journal:  J Clin Invest       Date:  2015-01-20       Impact factor: 14.808

6.  Reducing post-traumatic anxiety by immunization.

Authors:  Gil M Lewitus; Hagit Cohen; Michal Schwartz
Journal:  Brain Behav Immun       Date:  2008-06-17       Impact factor: 7.217

7.  Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways.

Authors:  Sarah R Jacobs; Catherine E Herman; Nancie J Maciver; Jessica A Wofford; Heather L Wieman; Jeremy J Hammen; Jeffrey C Rathmell
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

8.  NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells.

Authors:  Steven W Paugh; Erik J Bonten; Daniel Savic; Laura B Ramsey; William E Thierfelder; Prajwal Gurung; R K Subbarao Malireddi; Marcelo Actis; Anand Mayasundari; Jaeki Min; David R Coss; Lucas T Laudermilk; John C Panetta; J Robert McCorkle; Yiping Fan; Kristine R Crews; Gabriele Stocco; Mark R Wilkinson; Antonio M Ferreira; Cheng Cheng; Wenjian Yang; Seth E Karol; Christian A Fernandez; Barthelemy Diouf; Colton Smith; J Kevin Hicks; Alessandra Zanut; Audrey Giordanengo; Daniel Crona; Joy J Bianchi; Linda Holmfeldt; Charles G Mullighan; Monique L den Boer; Rob Pieters; Sima Jeha; Thomas L Dunwell; Farida Latif; Deepa Bhojwani; William L Carroll; Ching-Hon Pui; Richard M Myers; R Kiplin Guy; Thirumala-Devi Kanneganti; Mary V Relling; William E Evans
Journal:  Nat Genet       Date:  2015-05-04       Impact factor: 38.330

9.  PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation.

Authors:  Nikolaos Patsoukis; Kankana Bardhan; Pranam Chatterjee; Duygu Sari; Bianling Liu; Lauren N Bell; Edward D Karoly; Gordon J Freeman; Victoria Petkova; Pankaj Seth; Lequn Li; Vassiliki A Boussiotis
Journal:  Nat Commun       Date:  2015-03-26       Impact factor: 14.919

10.  IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity.

Authors:  Minkyung Song; Tito A Sandoval; Chang-Suk Chae; Sahil Chopra; Chen Tan; Melanie R Rutkowski; Mahesh Raundhal; Ricardo A Chaurio; Kyle K Payne; Csaba Konrad; Sarah E Bettigole; Hee Rae Shin; Michael J P Crowley; Juan P Cerliani; Andrew V Kossenkov; Ievgen Motorykin; Sheng Zhang; Giovanni Manfredi; Dmitriy Zamarin; Kevin Holcomb; Paulo C Rodriguez; Gabriel A Rabinovich; Jose R Conejo-Garcia; Laurie H Glimcher; Juan R Cubillos-Ruiz
Journal:  Nature       Date:  2018-10-10       Impact factor: 49.962

View more
  2 in total

1.  The Role of β-Adrenergic Receptors in the Regulation of the Functions of Innate Immune Cells during Cold Stress In Vivo.

Authors:  S V Gein; A V Karnaukhova
Journal:  Bull Exp Biol Med       Date:  2022-05-26       Impact factor: 0.804

Review 2.  COVID-19 and obesity in childhood and adolescence: a clinical review.

Authors:  Carlos Alberto Nogueira-de-Almeida; Luiz A Del Ciampo; Ivan S Ferraz; Ieda R L Del Ciampo; Andrea A Contini; Fábio da V Ued
Journal:  J Pediatr (Rio J)       Date:  2020-08-04       Impact factor: 2.990

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.